These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pulmonary exacerbations in cystic fibrosis: young children with characteristic signs and symptoms. Regelmann WE; Schechter MS; Wagener JS; Morgan WJ; Pasta DJ; Elkin EP; Konstan MW; Pediatr Pulmonol; 2013 Jul; 48(7):649-57. PubMed ID: 22949088 [TBL] [Abstract][Full Text] [Related]
6. Home versus hospital intravenous antibiotic therapy for acute pulmonary exacerbations in children with cystic fibrosis. Nazer D; Abdulhamid I; Thomas R; Pendleton S Pediatr Pulmonol; 2006 Aug; 41(8):744-9. PubMed ID: 16779852 [TBL] [Abstract][Full Text] [Related]
8. [Antibiotic therapy and effects of respiratory physiotherapy techniques in cystic fibrosis patients treated for acute lung exacerbations: an experimental study]. da Silva Santos CI; Gonçalves de Oliveira Ribeiro MA; Moreno Morcillo A; Fernando Ribeiro A; Dirceu Ribeiro J Arch Bronconeumol; 2010 Jun; 46(6):310-6. PubMed ID: 20417019 [TBL] [Abstract][Full Text] [Related]
9. Recurrent exacerbations affect FEV(1) decline in adult patients with cystic fibrosis. Amadori A; Antonelli A; Balteri I; Schreiber A; Bugiani M; De Rose V Respir Med; 2009 Mar; 103(3):407-13. PubMed ID: 19027279 [TBL] [Abstract][Full Text] [Related]
10. Improved lung function and body mass index associated with long-term use of Macrolide antibiotics. Pirzada OM; McGaw J; Taylor CJ; Everard ML J Cyst Fibros; 2003 Jun; 2(2):69-71. PubMed ID: 15463852 [TBL] [Abstract][Full Text] [Related]
11. Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria. Block JK; Vandemheen KL; Tullis E; Fergusson D; Doucette S; Haase D; Berthiaume Y; Brown N; Wilcox P; Bye P; Bell S; Noseworthy M; Pedder L; Freitag A; Paterson N; Aaron SD Thorax; 2006 Nov; 61(11):969-74. PubMed ID: 16844728 [TBL] [Abstract][Full Text] [Related]
12. Impact of acute antibiotic therapy on the pulmonary exacerbation endpoint in cystic fibrosis clinical trials. Mayer-Hamblett N; Saiman L; Lands LC; Anstead M; Rosenfeld M; Kloster M; Fisher L; Ratjen F Contemp Clin Trials; 2013 Sep; 36(1):99-105. PubMed ID: 23770109 [TBL] [Abstract][Full Text] [Related]
13. Determining presence of lung disease in young children with cystic fibrosis: lung clearance index, oxygen saturation and cough frequency. Bakker EM; van der Meijden JC; Nieuwhof EM; Hop WC; Tiddens HA J Cyst Fibros; 2012 May; 11(3):223-30. PubMed ID: 22265603 [TBL] [Abstract][Full Text] [Related]
14. Exhaled breath condensate pH and ammonia in cystic fibrosis and response to treatment of acute pulmonary exacerbations. Newport S; Amin N; Dozor AJ Pediatr Pulmonol; 2009 Sep; 44(9):866-72. PubMed ID: 19670404 [TBL] [Abstract][Full Text] [Related]
15. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype. De Boeck K; Weren M; Proesmans M; Kerem E Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171 [TBL] [Abstract][Full Text] [Related]
16. Objective monitoring of cough in children with cystic fibrosis. Hamutcu R; Francis J; Karakoc F; Bush A Pediatr Pulmonol; 2002 Nov; 34(5):331-5. PubMed ID: 12357476 [TBL] [Abstract][Full Text] [Related]
17. Adherence to the 2007 cystic fibrosis pulmonary guidelines: a national survey of CF care centers. Glauser TA; Nevins PH; Williamson JC; Abdolrasulnia M; Salinas GD; Zhang J; Debonnett L; Riekert KA Pediatr Pulmonol; 2012 May; 47(5):434-40. PubMed ID: 22495970 [TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of sputum from adults and children with cystic fibrosis and from control subjects. Sloane AJ; Lindner RA; Prasad SS; Sebastian LT; Pedersen SK; Robinson M; Bye PT; Nielson DW; Harry JL Am J Respir Crit Care Med; 2005 Dec; 172(11):1416-26. PubMed ID: 16166615 [TBL] [Abstract][Full Text] [Related]
19. The impact of treatment of pulmonary exacerbations on the health-related quality of life of patients with cystic fibrosis: does hospitalization make a difference? Yi MS; Tsevat J; Wilmott RW; Kotagal UR; Britto MT J Pediatr; 2004 Jun; 144(6):711-8. PubMed ID: 15192614 [TBL] [Abstract][Full Text] [Related]
20. Effects of montelukast treatment on clinical and inflammatory variables in patients with cystic fibrosis. Stelmach I; Korzeniewska A; Stelmach W; Majak P; Grzelewski T; Jerzynska J Ann Allergy Asthma Immunol; 2005 Oct; 95(4):372-80. PubMed ID: 16279568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]